Autres langues XTL Biopharmaceuticals Ltd.

Actions

XTLB

IL0010854979

Marché Fermé - TEL AVIV STOCK EXCHANGE Autres places de cotation 16:24:35 04/07/2024			Varia. 5j.	Varia. 1 janv.
8,2 ^ILa	-1,20%		+2,50%	+134,29%

05/06	XTL Biopharmaceuticals signe un accord pour acquérir The Social Proxy	MT
13/05	XTL Biopharmaceuticals Ltd. publie ses résultats pour le premier trimestre clos le 31 mars 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

XTL Biopharmaceuticals : Immediate Report of Meeting	12/06
XTL Biopharmaceuticals : NOTICE OF ANNUAL AND EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON JULY 22, 2024 Form 6 K	12/06
XTL Biopharmaceuticals Signs Deal to Acquire The Social Proxy	05/06
XTL Biopharmaceuticals Ltd. announced that it has received $1.5 million in funding	05/06
XTL Biopharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	13/05
XTL Biopharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	30/04
Top Premarket Gainers	29/04
XTL Biopharmaceuticals : Report Of Foreign Private Issuer - Form 6-K	02/04
XTL Biopharmaceuticals : Immediate Report of Meeting	21/03
XTL Biopharmaceuticals : NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON APRIL 30, 2024 - Form 6-K	21/03
Top Midday Gainers	20/03
XTL Biopharmaceuticals to Acquire The Social Proxy; Shares Soar	20/03
XTL To Aquire The Social Proxy	20/03
XTL Biopharmaceuticals Ltd. announced that it expects to receive $1.5 million in funding	20/03
XTL Biopharmaceuticals Ltd. entered into a binding term sheet to acquire THE SOCIAL PROXY Ltd.	20/03
XTL Biopharmaceuticals Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	15/11
XTL Biopharmaceuticals : Report Of Foreign Private Issuer - Form 6-K	15/11
XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency	20/10/23
XTL Biopharmaceuticals : OPERATING AND FINANCIAL REVIEW AND PROSPECTS (Form 6-K)	25/08/21
XTL Biopharmaceuticals Ltd. Elects Alexander Rabinovitch as Directors	03/08/17

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues XTL Biopharmaceuticals Ltd.

Actions

XTLB

IL0010854979

Autres langues

Filtres